Community Pharmacists Behaviour During Covid-19

Covid19 Clinical Trial

Official title:

SURVEY of RETAIL PHARMACISTS KNOWLEDGE, ROLE & BEHAVIOR DURING COVID-19 VIRUS OUTBREAK

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04374513
• Other study ID #: Pharmacists and covid-19
• Status: Completed
• Start date: April 2, 2020
• Est. completion date: July 1, 2020

Study information

• Verified date: April 2020
• Source: Damanhour University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

During the COVID-19 pandemic, governments issued movement restrictions and placed areas into quarantine to reduce the spread of the disease.Community pharmacists and their teams are a vital healthcare provider during the outbreak; they remain on the frontline of public health by serving as direct points of access for their patients. The retail pharmacists should provide public community, costumers and patients with right and trusted information about covid-19. They also should have role in awareness spreading regarding personnel safety and hygiene

Description:

The survey will enroll as many community pharmacists as possible in the survey portion of the study - The number of participates have no limitations, at least 50 participants.

The survey will be enrolled in online google form, face to face interview & semi-structured telephone interviews if possible.

The research procedures:

1. An online survey link will include questions regarding the impact of role and behavior of retail pharmacists during covid-19 outbreak.

2. Face to face and semi-structured interviews if possible: For those pharmacists who state that they would like to participate in an interview, a random sample will be contacted.

Inclusion Criteria:

1. Post graduated pharmacist.

2. Community pharmacists.

Exclusion Criteria:

1. under graduated students.

2. not pharmacist.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 318
• Est. completion date: July 1, 2020
• Est. primary completion date: June 1, 2020
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Post graduated pharmacist. Community pharmacists.

Exclusion Criteria:

• under graduated students. not pharmacist.

Related Conditions & MeSH terms

• Covid19

Locations

Country	Name	City	State
Egypt	Damanhour universty	Alexandria
Egypt	Damanhour university	Beheira	Damanhour

Sponsors (1)

Lead Sponsor	Collaborator
Damanhour University

Country where clinical trial is conducted

Egypt, 

References & Publications (3)

Bukhari N, Rasheed H, Nayyer B, Babar ZU. Pharmacists at the frontline beating the COVID-19 pandemic. J Pharm Policy Pract. 2020 Apr 20;13:8. doi: 10.1186/s40545-020-00210-w. eCollection 2020. — View Citation

Farooq A, Laato S, Islam AKMN. Impact of Online Information on Self-Isolation Intention During the COVID-19 Pandemic: Cross-Sectional Study. J Med Internet Res. 2020 May 6;22(5):e19128. doi: 10.2196/19128. — View Citation

Rutter V, Chan AHY, Tuck C, Bader L, Babar ZU, Bates I. Weaving the health and pharmaceutical care agenda through the themes of the commonwealth heads of government meeting (CHOGM), London 2018. J Pharm Policy Pract. 2018 Apr 11;11:10. doi: 10.1186/s40545-018-0140-3. eCollection 2018. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	community pharmacists facing covid-19	Evaluate the knowledge, role & behavior of retail pharmacists in facing covid-19 virus through the survey	6 months